Farmingdale Medicaid providers billed at least $3,521 for COVID-19 care in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows that Medicaid payments for COVID-19–related services in Farmingdale reached at least $3,521 in 2024, based on HCPCS codes flagged specifically for COVID-19.

Medicaid, a public health insurance program run by each state and funded through joint contributions from federal and state governments, provides coverage for low-income people, seniors, children, and those with disabilities, making it a key component of the U.S. health care system.

Taxpayer contributions fund Medicaid payments, so shifts in local billing levels provide insight into how public health care resources are distributed within each community.

Researchers identified COVID-19–related services using HCPCS codes marked as “COVID-19” or “coronavirus” in the billing descriptions or reference sources. Therefore, these totals only capture services directly identified as COVID-related and exclude others that may have been coded more broadly.

Comparatively, in New York, Brooklyn saw the state’s highest Medicaid spending on COVID-19 services for 2024, with $3,718,101 in claims.

The lone provider in Farmingdale to submit Medicaid claims for COVID-19–related care in 2024 was Ronald C Fagan Md, Pc, the data indicates.

Pandemic-era service claims caused a notable rise in COVID-19–specific Medicaid spending in Farmingdale during that period.

Average annual Medicaid payments in Farmingdale during the two years before the pandemic reached $6,199,031.

According to the Centers for Medicare & Medicaid Services, total federal and state Medicaid spending climbed to about $871.7 billion in fiscal 2023, making up roughly 18% of overall U.S. health spending, a steep increase from $613.5 billion in 2019, before the pandemic began.

This shift reflects an increase of about 40% over several years, with main drivers including expanded program enrollment and higher service use during and after the public health emergency.

Recent federal budget changes during the Trump administration have included notable efforts to reduce federal Medicaid funds and restructure the program. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to cut federal Medicaid funding by more than $1 trillion in the coming decade. New provisions such as work requirements and increased cost-sharing could reduce access and funding for some participants, shifting additional costs to states while federal Medicaid growth slows, even though the program continues to cover tens of millions of Americans.

Medicaid Payments in Farmingdale Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $3,521 -95.6% $3,981,015
2023 $80,497 -97% $8,392,308
2022 $2,641,003 -48.2% $13,359,281
2021 $5,093,706 192.3% $14,058,512
2020 $1,742,909 N/A $9,237,300
2019 $0 N/A $7,585,452
2018 $0 N/A $4,812,610
Top COVID-19–Related HCPCS Codes in Farmingdale
HCPCS Code Description Medicaid Payments Claims
86769 Immunoassay $3,521 145

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

Information used in this report comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data is available here.



Related

Sean R. Keveney J.D., Chief Counsel of FDA

FDA inspects Swadesh Board USA, Inc. in Farmingdale on March 20, issues citation

On March 20, the FDA conducted an inspection at Swadesh Board USA, Inc. in Farmingdale for foodborne biological hazards and issued one violation.

Benjamin D. Moncarz Chief Financial Officer - FDA

FDA: 2 companies in cities within Nassau County received 4 citations in March

There were two companies in a city associated with Nassau County that received FDA citations as a result of two inspections conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

Sara Brenner, Principal Deputy Commissioner at FDA

Swadesh Board USA, Inc. in Farmingdale inspected by FDA for biological hazards March 20

FDA records show that Swadesh Board USA, Inc. in Farmingdale underwent a March 20 inspection related to foodborne biological hazards.